|Bid||241.79 x 1100|
|Ask||243.82 x 900|
|Day's range||237.81 - 244.18|
|52-week range||177.05 - 264.97|
|Beta (5Y monthly)||0.85|
|PE ratio (TTM)||19.92|
|Earnings date||22 Oct 2020 - 26 Oct 2020|
|Forward dividend & yield||6.40 (2.66%)|
|Ex-dividend date||14 Aug 2020|
|1y target est||262.76|
Biotech firms and drugmakers across the globe are pumping in millions of dollars to develop a vaccine to wipe out the deadly coronavirus.
A huge shakeup in the Dow following Apple's stock split could have meaningful portfolio ramifications for holders of any stocks involved.
While the biotech stares down a busy year ahead, shareholders should buckle up for an exciting ride.